|
SNRPB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.611500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.703000E-01 |
| Normal-vs-Stage2 |
6.163400E-01 |
| Normal-vs-Stage3 |
1.092090E-02 |
| Normal-vs-Stage4 |
1.211350E-01 |
| Stage1-vs-Stage2 |
9.386200E-01 |
| Stage1-vs-Stage3 |
3.045800E-02 |
| Stage1-vs-Stage4 |
8.961700E-02 |
| Stage2-vs-Stage3 |
5.648000E-02 |
| Stage2-vs-Stage4 |
1.748560E-01 |
| Stage3-vs-Stage4 |
7.963400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.594100E-02 |
| Normal-vs-AfricanAmerican |
7.378000E-02 |
| Normal-vs-Asian |
4.340000E-01 |
| Caucasian-vs-AfricanAmerican |
6.490200E-01 |
| Caucasian-vs-Asian |
7.981600E-01 |
| AfricanAmerican-vs-Asian |
9.079600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.976200E-01 |
| Normal-vs-Female |
1.246060E-02 |
| Male-vs-Female |
4.006500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.766380E-01 |
| Normal-vs-Extreme_Weight |
3.486600E-01 |
| Normal-vs-Obese |
2.386300E-02 |
| Normal-vs-Extreme_Obese |
1.882250E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.978600E-01 |
| Normal_Weight-vs-Obese |
6.687000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.684030E-01 |
| Extreme_Weight-vs-Obese |
1.861390E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.264600E-01 |
| Obese-vs-Extreme_Obese |
6.681900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.751800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.036500E-03 |
| Normal-vs-Age(61-80Yrs) |
9.403400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.603400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.809240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.814300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.112300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.204900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.506750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.469000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.978640E-01 |
| Normal-VS-Type2 PRCC |
2.324400E-01 |
| Normal-VS-KIRP CIMP |
2.217600E-01 |
| Normal-VS-Unclassified PRCC |
1.580980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.977600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.351600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.661200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.055800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.316000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.358200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.960600E-01 |
| Normal-vs-N1 |
3.497700E-03 |
| Normal-vs-N2 |
5.440000E-01 |
| N0-vs-N1 |
8.579700E-03 |
| N0-vs-N2 |
6.878800E-01 |
| N1-vs-N2 |
1.405810E-01 |
|
|
